Panzyga

Indicated For

Primary Immunodeficiency, Chronic Immune Thrombocytopenia, Chronic Inflammatory Demyelinating Polyneuropathy

About This Medication

# PANZYGA Patient Guide: How to Get Panzyga at Low or No Cost Panzyga (Immune Globulin Intravenous (Human) - ifas) is an immunoglobulin therapy used to treat conditions like primary humoral immunodeficiency (PI), chronic inflammatory demyelinating polyneuropathy (CIDP), and multifocal motor neuropathy (MMN). Pfizer offers **PANZYGA Co-Pay Programs** for eligible commercially insured patients to reduce out-of-pocket costs for the drug and administration, plus a special **Pfizer Pledge Warranty Program** for CIDP patients.[1][2][3] ## About Panzyga Panzyga is a sterile, preservative-free, lyophilized immune globulin administered intravenously to boost the immune system in patients with certain deficiencies or autoimmune conditions. It's FDA-approved for PI in adults and children 2+, CIDP in adults as maintenance therapy, and MMN in adults. Treatments often occur in infusion centers, hospitals, or at home, with dosing based on body weight and condition.[1][2] Common side effects include headache, fever, fatigue, and infusion reactions, but many patients tolerate it well. Always consult your doctor for personalized advice. This guide focuses on Pfizer's financial support to make treatment more affordable.[1] ## Who Qualifies for Pfizer's PANZYGA Programs? Pfizer provides **two main co-pay assistance programs** and a **warranty program**, primarily for **commercially insured patients** (private or employer-sponsored insurance). **Government-insured patients (Medicare, Medicaid, TRICARE, VA, etc.) are not eligible** for co-pay programs.[1][3][6] ### PANZYGA Co-Pay Program (Drug Costs) - **Eligible patients**: Commercially insured U.S. residents (including Puerto Rico) with a Panzyga prescription. - **Benefits**: Up to **$12,500 per calendar year** or your full co-pay, whichever is less. You may pay **as little as $0** per treatment.[1][3] - **What it covers**: Only drug co-pays, not administration, procedures, or office visits.[3] ### PANZYGA Admin Support Co-Pay Program - **Eligible patients**: Same as above, but **not available in Massachusetts or Rhode Island**. - **Benefits**: Up to **$1,500 per calendar year** for administration costs (home infusions, supplies, equipment), or your full co-pay, whichever is less.[1][3][7] ### Pfizer Pledge Warranty Program (CIDP Only) - **Eligible patients**: Adult cash-paying or commercially insured patients starting Panzyga for CIDP, **not covered by government insurance**. - **Benefits**: Refund of out-of-pocket drug costs for the first **4 treatments** if discontinued by your doctor for clinical reasons (before the 5th treatment). Limits: Up to $16,500 per treatment, $50,000 total aggregate.[2][9] **Note**: No income requirements for co-pay programs; eligibility is based on insurance type. For uninsured patients, see Pfizer RxPathways below.[4] ## Income Eligibility Breakdown Co-pay programs have **no income limits**, but Pfizer's **Patient Assistance Program (RxPathways)** offers **free medicine** to uninsured or government underinsured patients meeting income guidelines (up to **500-600% FPL** for specialty drugs like Panzyga).[4] Here's a table for 2026 Federal Poverty Level (FPL) guidelines at 500% (common for specialty products; confirm current levels): | Household Size | Annual Income Limit (500% FPL) | |----------------|-------------------------------| | 1 (Individual) | $75,300 | | 2 (Couple) | $102,000 | | 3 | $128,700 | | 4 | $155,400 | *Guidelines adjusted annually; visit Pfizer RxPathways for exact figures. Primary care products may be 300% FPL.[4]* ## Insurance Requirements - **Co-Pay Programs**: **Private/commercial insurance required**. No federal/state programs (Medicare Part D, Medicaid, etc.).[1][3][6] - **Pfizer Pledge**: Commercial or cash-pay only; government coverage disqualifies.[2] - **RxPathways (Free Drug)**: Uninsured or government underinsured (after exhausting other aid).[4] Contact your insurer first; Pfizer IGuide helps navigate coverage.[2][5] ## Step-by-Step Application Process 1. **Confirm Eligibility**: Verify commercial insurance and prescription for approved use. Use Pfizer IGuide at **www.PfizerIGuide.com** or call for pre-screening.[1][2] 2. **Enroll Online or by Phone**: - Visit **www.PfizerIGuide.com** for enrollment, financial assessment, and insurance support.[1][5] - Specialty infusion pharmacies can enroll you directly.[1] - Call Pfizer IGuide: 1-844-IGUIDE1 (1-844-448-4331).[10] 3. **Submit Co-Pay Card**: Get instant access to savings card for pharmacy or infusion center.[3] 4. **For RxPathways (Uninsured)**: - Doctor completes enrollment form. - Provide proof of income (W-2, tax return, paystub). - Submit via doctor's office or **www.PfizerrxPathways.com**.[4] 5. **For Pfizer Pledge (CIDP)**: Enroll via Panzyga website; track first 4 infusions.[2] No membership fees. Programs valid in U.S./Puerto Rico.[1] ## Timeline and Delivery - **Co-Pay Approval**: Instant upon enrollment; savings apply at point-of-service.[1][3] - **RxPathways Processing**: Varies; typically 2-4 weeks. Free meds shipped to doctor or home.[4] - **Delivery**: Via specialty pharmacy or infusion provider. Home infusion supported with Admin Co-Pay.[1] Refills auto-covered under annual limits; monitor calendar year caps.[3] ## Alternatives if Denied or Ineligible - **Switch Programs**: Try RxPathways if uninsured (up to 500-600% FPL).[4] - **Other Assistance**: PAN Foundation, HealthWell Foundation for immunoglobulins (income-based grants). - **Biosimilars/Alternatives**: No biosimilars listed; alternatives like Octagam or Cutaquig via Pfizer IGuide.[7] - **State Programs**: Check for local aid if government-insured. - **Appeal Insurance**: Pfizer IGuide assists with prior authorizations.[5] ## Disclaimer This guide is for informational purposes only and based on publicly available data as of 2026. Programs can change; always verify at **www.PfizerIGuide.com** or by phone. Not medical advice—consult your healthcare provider. Pfizer not liable for coverage decisions. Full terms at Pfizer sites.[1][2][3][4]

Program information last verified: March 30, 2026